Drug
Zw251
Zw251: highest development phase Phase 1, developed by Zymeworks. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Zymeworks
Trials
| Drug | Phase | Indication |
|---|---|---|
| ZW251 NCT07164313 | Phase 1 | Hepatocellular Carcinoma |
Latest
No recent events.
Follow Zw251 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.